CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers

NCT00822809 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Neoplasms
Carcinoma
Malignant Ascites

Interventions

DRUG: Catumaxomab
DRUG: Prednisolone

Sponsor

Neovii Biotech